Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for
Kevzara Enrollment Form. Kevzara is used to treat adult patients with: Web patient enrolment form for more information please contact:
Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for
Save or instantly send your ready documents. Web prescription & enrollment form: Return all completed sections of this consent form through the patientby mail or by fax assistance program, connect Kevzara (sarilumab) for pmr fax completed form to 888.302.1028. Web patient consent and enrollment form instructions to ensure your information is processed without delay: Web now approved to treat adult patients with polymyalgia rheumatica (pmr) who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper. Web complete kevzara enrollment form online with us legal forms. Kevzara is used to treat adult patients with: All information will bekept confidential and will not be released to unauthorized parties without your consent. Web patient enrolment form for more information please contact:
Register today when it’s time for a change, target. Kevzara is used to treat adult patients with: Web now approved to treat adult patients with polymyalgia rheumatica (pmr) who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper. Approval press release you're invited to an expert data presentation on the kevzara indication for pmr. Easily fill out pdf blank, edit, and sign them. Please see important safety information including boxed warning, and full pi on website. Kevzara (sarilumab) for pmr fax completed form to 888.302.1028. Return all completed sections of this consent form through the patientby mail or by fax assistance program, connect For questions regarding the patient assistance program, please call. Save or instantly send your ready documents. Patient’s irst name last name middle initial date of birth
